Neoventa Medical AB is a medtech company developing monitoring and management tools for improved perinatal healthcare. The company is based in Molndal close to Goteborg in Sweden. Neoventa has combined a unique medical expertise with digital signal processing technology to establish ST analysis of the fetal heart as one of the most exciting advances within the field of perinatal medicine. STAN™ S31 is the latest of a series of products for this purpose.

STAN™ is a system for monitoring the fetal heart function. It is based on unique methodology and patented digital signal processing technology. STAN is capable of identifying babies at risk of suffering of oxygen deficiency resulting from the stress of labour.

The fetal ECG waveform changes if the heart is exposed to hypoxia. These changes are detected and automatically analysed by the STAN S31 fetal monitor, providing key information about the fetal state.

The Gold Standard for fetal ECG
Decision-making during labour requires continuous, clear information about fetal status. This is in turn totally dependent on the quality of the signals recorded by the fetal monitor.

Goldtrace™ is the first fetal scalp electrode designed specifically for use with ST analysis, STAN™, where full fetal ECG, rather than only heart rate is recorded. The electrode spiral and reference are gold plated and provide superior signal quality. Goldtrace can also be used as a standard CTG electrode.